Centaur has been able to carve a niche
as India's leading manufacturer and exporter of APIs based on intellectual strength,
core competence and a right vision. This vision has translated into
Centaur
being the
first in India to manufacture Clobazam, Clonazepam,
Melitracen, Metolazone, Nortriptyline, Oxazepam, Zaleplon, Zolpidem and Zopiclone
bulk actives.
Our current API portfolio comprises of
| Alprazolam |
Benzydamine HCl |
| Brimonidine Tartrate |
Bromazepam |
| Chlordiazepoxide |
Clonazepam |
| Clobazam |
Clorazepate Dipotassium |
| Diazepam |
Flupentixol Dihydrochloride |
| Fluphenazine HCl |
Lorazepam |
| Melitracen HCl |
Methyl Phenidate HCl |
| Metolazone |
Midazolam |
| Midazolam HCl |
Midazolam Maleate |
| Nitrazepam |
Nortriptyline HCl |
| Oxazepam |
Quazepam |
| Timolol Maleate |
Triazolam |
| Zaleplon |
Zolpidem Tartrate |
| Zopiclone |
|
Products under development:
| 1) Olopatadine HCl |
| 2) Tetrazepam |
| 3) Clotiazepam |
| 4) Eszopiclone |
| 5) Mepacrine HCl |
Products to be developed:
1) Medazepam
(These products are not available for exports if there is a valid patent in the country of import. The responsibility of importing is solely with the importer.)
